Introduction: As Meta Description
At Art of Healing Cancer, the fusion of Precision Oncology, modern medicine, and traditional healing practices forms the cornerstone of our patient-centered treatment philosophy. Recognizing the uniqueness of each individual’s battle with cancer, we integrate cutting-edge genomic sequencing and the latest medical advancements to tailor treatment plans that are as unique as the patients themselves. Simultaneously, we embrace the wisdom of traditional medicine, acknowledging its role in nurturing the whole person – body, mind, and spirit. This holistic approach not only targets the cancer cells but also supports the overall well-being of our patients, helping them to maintain a better quality of life throughout their treatment journey. By blending these diverse modalities, Art of Healing Cancer offers a compassionate, comprehensive care plan that addresses the multifaceted challenges of cancer, ensuring that each patient receives the most effective, personalized therapy.
Please share your contact details for our teams to connect and guide you through your treatment plans
At Art of Healing Cancer, we pride ourselves on having a team of highly skilled and compassionate experts in cancer treatment. Our specialists, drawn from diverse fields of oncology, integrate the latest advancements in modern medicine with traditional healing practices. This unique blend ensures that each patient receives a holistic treatment plan, tailored to their specific needs. Our team includes renowned oncologists, experienced surgeons, dedicated nurses, and supportive care professionals who work together to provide comprehensive care. To meet our esteemed team and learn more about their expertise and contributions in the field of cancer treatment, please visit our dedicated page here.
Blending traditional and modern treatments, we offer a holistic approach to cancer care.
Through chemosensitivity planning, we customize chemotherapy to each patient’s unique needs.
Precision and improved outcomes are hallmarks of our state-of-the-art robotic surgery techniques.
Utilizing genomic and transcriptomic data analysis, we provide the most advanced targeted therapy options.
As the only institution in India combining genomic and transcriptomic data with natural and herbal treatments, we offer comprehensive care.
We offer the most advanced immunotherapy treatments, including tailored vaccines and sensitivity testing to immunotherapy drugs.
One of the only centres trained on exploiting tumor Metabolism
We can grow cancer cells from blood in 3D tumors to analyse the cancer characteristics
Impact of Slow- Infusion (Metronomic) 2-Deoxy-D-Glucose in Treatment of Refractory Patient of Gliobalstoma Multiforme
The cost of treating cancer, including peritoneal cancer can vary widely based on the type of treatment, the severity and stage of the cancer, and other individual factors. Here’s a breakdown of the costs associated with various cancer treatments:
The cost for surgery can range from ₹305,200 ($3791) to ₹11,44,500 ($14216), depending on the specific requirements of the surgery.
Peritoneal cancer is a rare but serious type of cancer that occurs in the peritoneum, a thin layer of tissue lining the inside of the abdomen. This lining provides a protective cover for the abdominal organs and serves as a lubricated surface allowing organ movement.
A rare cancer starting in the peritoneum, similar to epithelial ovarian cancer but can occur without ovaries. It arises from the peritoneum’s cells, distinct from ovarian involvement.
Also known as peritoneal carcinomatosis, it results from the spread of other cancers (like stomach, colon) to the peritoneum, with treatment depending on the primary cancer’s origin.
A rare, aggressive cancer linked to asbestos exposure, affecting the abdominal lining and presenting with symptoms like pain and swelling.
An aggressive, rare cancer affecting mainly young males, characterized by small, round cells, often widespread at diagnosis, posing treatment challenges.
Tests like the CA-125 can indicate peritoneal cancer by measuring specific protein levels, though results may vary with other conditions.
The conclusive method for diagnosing peritoneal cancer, involving tissue sample examination.
Risk is higher in those with a family history of peritoneal, ovarian, or breast cancer, often due to BRCA1 and BRCA2 gene mutations.
More common in women and individuals over 60, suggesting accumulated risk factors over time.
This condition can increase risk by causing inflammation and cellular changes in the peritoneum.
Past surgeries or chronic abdominal inflammation may heighten risk by altering peritoneal cells.
Linked to peritoneal mesothelioma, asbestos fibers can cause long-term inflammation and cancer in the peritoneum.
Obesity and smoking might indirectly increase risk through inflammation and bodily changes.
Persistent or intermittent abdominal pain that may be vague and not localized to any specific area. It’s essential to pay attention to ongoing discomfort, even if it’s mild.
Noticeable increase in abdominal size or persistent bloating unrelated to meal intake, often caused by fluid accumulation (ascites) in the abdominal cavity, commonly associated with peritoneal cancer.
Peritoneal cancer can cause noticeable alterations in bowel movements, including constipation or diarrhea. These changes are often variable and should be monitored if they persist.
These symptoms may manifest, particularly if the cancer affects the stomach or significant fluid buildup occurs in the abdomen, potentially impacting digestive processes.
This early satiety, or feeling full after consuming only a small meal, can lead to a reduced appetite and subsequent weight loss, which is a concerning symptom.
Any significant weight loss that occurs without changes in diet or exercise routines can be a red flag for peritoneal cancer, especially when coupled with other symptoms on this list.
A deep, unrelenting tiredness that doesn’t improve with rest, limiting the ability to perform daily activities, can be indicative of peritoneal cancer among other conditions.
In stage I, the cancer has not spread beyond the peritoneum or the pelvis. Treatment at this early stage often involves surgery and may have a more favorable outcome.
At stage II, the cancer has begun to spread beyond the pelvis but is still within the abdominal cavity. Treatment may involve more extensive surgery combined with chemotherapy.
Stage III indicates more significant spreading, which may involve lymph nodes and a wider area of the abdominal cavity. Treatment often involves a combination of surgery to remove as much cancer as possible and chemotherapy to target cancer cells.
Stage IV peritoneal cancer has spread beyond the abdomen to distant parts of the body, such as the lungs or bones. This stage signifies advanced disease and may require a more aggressive treatment approach, including chemotherapy, targeted therapy, and palliative care to manage symptoms and improve quality of life.
Administering high-dose Vitamin C intravenously, this therapy is explored for its potential to produce hydrogen peroxide, which may target cancer cells, enhance life quality, and mitigate side effects of traditional treatments.
An innovative therapy where patients inhale molecular hydrogen gas, leveraging its antioxidant properties to potentially reduce oxidative stress in cancer cells. Its efficacy and safety in humans are subjects of ongoing research.
Involves breathing pure oxygen in a pressurized environment, believed to enhance tissue oxygenation and aid healing. Used cautiously in cancer care to potentially improve chemotherapy and radiation effectiveness and manage side effects.
Utilizes extracts from the European mistletoe plant, injected to possibly stimulate the immune system and exert cytotoxic effects on cancer cells. While popular in Europe for quality of life improvement, its scientific validation remains mixed.
An ancient Indian practice focusing on body system balance through diet, herbal treatment, and yogic breathing. Aimed at detoxification, boosting defense mechanisms, and overall well-being, it complements conventional treatments despite limited clinical trial evidence.
Uses cytotoxic drugs to target rapidly dividing cancer cells, administered intravenously, orally, or by injection. Types include Anthracyclines, Taxanes, Alkylating Agents, and Antimetabolites. Can be neoadjuvant (before surgery), adjuvant (after surgery), or palliative.
Focuses on specific genes or proteins involved in cancer growth.
Enhances the body’s immune response against cancer.
Uses high-energy beams to kill or halt cancer cell growth.
Customizes treatment based on genetic profiling of cancer.
Complementary approaches focusing on well-being and symptom management.
Each treatment option is chosen based on individual patient factors, cancer stage, and overall health, offering a comprehensive approach to peritoneum cancer management.
WhatsApp us